共 15 条
[1]
中国成人血脂异常防治指南[J] 中华心血管病杂志 2007, 05
[2]
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult[J] Todd J. Anderson;Jean Grégoire;Robert A. Hegele;Patrick Couture;G.B. John Mancini;Ruth McPherson;Gordon A. Francis;Paul Poirier;David C. Lau;Steven Grover;Jacques Genest;André C. Carpentier;Robert Dufour;Milan Gupta;Richard Ward;Lawrence A. Leiter;Eva Lonn;Dominic S. Ng;Glen J. Pearson;Gillian M. Yates;James A. Stone;Ehud Ur Ca
[3]
What Is the Role of Advanced Lipoprotein Analysis in Practice?[J] Jennifer G. Robinson Journal of the American College of Cardiology 2012,
[4]
Should we use apoB for risk assessment and as a target for treatment? ?[J] W. Virgil Brown;Gary L. Myers;Allan D. Sniderman;Evan Stein Journal of Clinical Lipidology 2010,
[5]
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations[J] Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson;Norm Campbell;André Carpentier;Patrick Couture;Robert Dufour;George Fodor;Gordon A. Francis;Steven Grover;Milan Gupta;Robert A. Hegele;David C. Lau;Lawrence Leiter;Gary F. Lewis;Eva Lonn;G.B. John Mancini;Dominic Ng;Glen J. Pearson;Allan Sniderman;James A.
[6]
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men[J] Paul M Ridker;Nina P. Paynter;Nader Rifai;J Michael Gaziano;Nancy R. Cook Circulation 2008,
[7]
Beyond Low-Density Lipoprotein Cholesterol[J] James O. Mudd;Barry A. Borlaug;Peter V. Johnston;Brian G. Kral;Rosanne Rouf;Roger S. Blumenthal;Peter O. Kwiterovich Journal of the American College of Cardiology 2007,
[8]
Oxidation of Low-Density Lipoprotein Cholesterol Following Administration of Poloxamer 407 to Mice Results From an Indirect Effect[J] Thomas P Johnston;Xinghua Zhou Journal of Cardiovascular Pharmacology 2007,
[9]
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines[J] Scott M. Grundy;James I. Cleeman;C. Noel Bairey Merz;H. Bryan Brewer;Luther T. Clark;Donald B. Hunninghake;Richard C. Pasternak;Sidney C. Smith;Neil J. Stone Circulation: Journal of the American Heart Association 2004,
[10]
C-reactive protein and risk of cardiovascular disease: Evidence and clinical application[J] Paul M. Ridker;Shari S. Bassuk;Peter P. Toth Current Atherosclerosis Reports 2003,

